Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
NYSE:KVUE

Kenvue Q3 2026 Earnings Date & Estimates

Kenvue logo
$19.89 +0.85 (+4.44%)
Closing price 10/22/2026 03:59 PM Eastern
Extended Trading
$19.76 -0.13 (-0.63%)
As of 07:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kenvue is scheduled to report Q3 2026 earnings on Friday, October 30, 2026, before market opens. The conference call is scheduled for 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Kenvue in Q3 2026

Kenvue is expected to post earnings of $0.2915 per share on revenue of $3.86 billion. In the same quarter a year earlier Kenvue reported $0.28 per share on revenue of $3.76 billion. Kenvue last reported on August 6, 2026, posting $0.31 per share and missing the $0.3187 consensus estimate. Kenvue has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.2915
Expected Revenue
$3.86 billion
Prior-Year EPS
$0.28
Prior-Year Revenue
$3.76 billion
Expected EPS Growth
+4.1%
Expected Revenue Growth
+2.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.31 (Missed by -$0.0087)
Last Quarter Revenue
$3.96 billion
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

Kenvue Q3 2026 Earnings FAQ

Kenvue (NYSE:KVUE) has confirmed it will report Q3 2026 earnings on Friday, October 30, 2026, before market opens.

Kenvue's Q3 2026 earnings conference call is scheduled for Friday, October 30, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Kenvue to post earnings of $0.2915 per share for Q3 2026.

The consensus revenue estimate for Kenvue is $3.86 billion for Q3 2026.

Kenvue Earnings Headlines

Kenvue (KVUE) Set to Post Quarterly Earnings on Friday
October 23 at 2:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31148260
Kenvue to Announce Third Quarter 2026 Results on October 30, 2026
October 21 at 5:00 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20261021129509/en/kenvue-to-announce-third-quarter-2026-results-on-october-30-2026/
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
October 23 at 1:00 AM  |  Banyan Hill Publishing (Ad)
ETFs Are Net Sellers of Kenvue (KVUE) on Oct. 16
October 20 at 8:12 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/etfs-net-sellers-kenvue-kvue-110306754.html
Market Chatter: Kimberly-Clark Sells Bonds to Help Finance Kenvue Acquisition
October 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/market-chatter-kimberly-clark-sells-132924754.html
Financial Analysis: Nature's Sunshine Products (NASDAQ:NATR) versus Kenvue (NYSE:KVUE)
October 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31124866
See More Kenvue Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kenvue? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kenvue and other key companies, straight to your email.

About Kenvue

Kenvue (NYSE:KVUE) is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson’s and OGX in oral care, baby care and hair care. Kenvue products are sold in markets around the world, with operations and commercial activities serving consumers across North America, Europe, Asia-Pacific, Latin America and other international regions.

Kenvue was established as an independent publicly traded company following its separation from Johnson & Johnson in 2023. The company is headquartered in Skillman, New Jersey, and has been led by Chief Executive Officer Thibaut Mongon. Its business is focused on building globally recognized consumer health brands and developing products for self-care, skin care, personal care and family health.

View Kenvue Profile
Earnings Tools